儿童IgA血管炎肾炎预后危险因素分析

doi:10.12372/jcp.2023.23e0697

Abstract

Abstract:

IgA vasculitis (IgAV) is the most common systemic small vessel vasculitis in children, and it is called IgA vasculitis with nephritis (IgAVN) when it affects the kidneys. Renal damage eventually lead to chronic kidney disease in about 20% children with IgAVN, and accounting for 1%~2% of all childhood end-stage renal disease (ESRD). Therefore, it is important to identify the risk factors for the prognosis of IgAVN in children and give timely and effective intervention for the prognosis of IgAVN. This article reviews the risk factors affecting the prognosis of IgAVN in children, in order to provide reference for clinical decision-making.

Key words: IgA vasculitis, IgA vasculitis with nephritis, prognosis, risk factor, child

NIE Xiaojing, CHEN Yi. Analysis of prognostic risk factors of IgA vasculitis with nephritis in children[J].Journal of Clinical Pediatrics, 2023, 41(12): 895-902.

References 61

[1]	Davin JC, Coppo R. Henoch-Schönlein purpura nephritis in children[J]. Nat Rev Nephrol, 2014, 10(10): 563-573. doi: 10.1038/nrneph.2014.126
[2]	Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international Chapel Hill consensus conference nomen-clature of vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11. doi: 10.1002/art.v65.1
[3]	Oni L, Sampath S. Childhood IgA vasculitis (Henoch Schönlein Purpura)-advances and knowledge gaps[J]. Front Pediatr, 2019, 7: 257. doi: 10.3389/fped.2019.00257
[4]	Calviño MC, Llorca J, García-Porrúa C, et al. Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study[J]. Medicine (Baltimore), 2001, 80(5): 279-290. doi: 10.1097/00005792-200109000-00001
[5]	Calvo-Río V, Loricera J, Mata C, et al. Henoch-Schönlein purpura in northern Spain: clinical spectrum of the disease in 417 patients from a single center[J]. Medicine (Baltimore), 2014, 93(2): 106-113. doi: 10.1097/MD.0000000000000019
[6]	Kang Y, Park JS, Ha YJ, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura[J]. J Korean Med Sci, 2014, 29(2): 198-203. doi: 10.3346/jkms.2014.29.2.198 pmid: 24550645
[7]	Trapani S, Micheli A, Grisolia F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature[J]. Semin Arthritis Rheum, 2005, 35(3): 143-153. doi: 10.1016/j.semarthrit.2005.08.007
[8]	Soylemezoglu O, Ozkaya O, Ozen S, et al. Henoch-Schönlein nephritis: a nationwide study[J]. Nephron Clin Pract, 2009, 112(3): c199-c204. doi: 10.1159/000218109
[9]	Nong BR, Huang YF, Chuang CM, et al. Fifteen-year experience of children with Henoch-Schönlein purpura in southern Taiwan, 1991-2005[J]. J Microbiol Immunol Infect, 2007, 40(4): 371-376.
[10]	Goldstein AR, White RH, Akuse R, et al. Long-term follow-up of childhood Henoch-Schönlein nephritis[J]. Lancet, 1992, 339(8788): 280-282. doi: 10.1016/0140-6736(92)91341-5 pmid: 1346291
[11]	Ronkainen J, Nuutinen M, Koskimies O. The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study[J]. Lancet, 2002, 360(9334): 666-670. doi: 10.1016/S0140-6736(02)09835-5 pmid: 12241872
[12]	Gardner-Medwin JMM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins[J]. Lancet, 2002, 360(9341): 1197-1202. doi: 10.1016/S0140-6736(02)11279-7 pmid: 12401245
[13]	Kang Z, Xun M, Li Z, et al. Association of the clinicopathological characteristics and proteinuria remission of pediatric IgAV with nephrotic-range proteinuria: a retrospective cohort study[J]. Front Pediatr, 2022, 10: 959212. doi: 10.3389/fped.2022.959212
[14]	Kurt-Şükür ED, Sekar T, Tullus K. Biopsy-proven Henoch-Schönlein purpura nephritis: a single center experience[J]. Pediatr Nephrol, 2021, 36(5): 1207-1215. doi: 10.1007/s00467-020-04809-8 pmid: 33089378
[15]	李华荣, 陈朝英, 涂娟, 等. 儿童紫癜性肾炎预后不良相关因素分析[J]. 中华肾脏病杂志, 2020, 36(7): 535-542. doi: 10.3760/cma.j.cn441217-20191125-00098
[16]	Taal MW, Brenner BM. Renal risk scores: progress and prospects[J]. Kidney Int, 2008, 73(11): 1216-1219. doi: 10.1038/ki.2008.36 pmid: 18322541
[17]	Verhave JC, Gansevoort RT, Hillege HL, et al. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population[J]. Kidney Int Suppl, 2004, 66(92):S18-S21.
[18]	Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end-stage renal disease[J]. Kidney Int, 2003, 63(4): 1468-1474. doi: 10.1046/j.1523-1755.2003.00868.x pmid: 12631363
[19]	Piram M, Maldini C, Biscardi S, et al. Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study[J]. Rheumatology (Oxford), 2017, 56(8): 1358-1366. doi: 10.1093/rheumatology/kex158 pmid: 28444335
[20]	Shi M, Yu S, Ouyang Y, et al. Increased lifetime risk of ESRD in familial IgA nephropathy[J]. Kidney Int Rep, 2021, 6(1) : 91-100. doi: 10.1016/j.ekir.2020.10.015 pmid: 33426388
[21]	Kiryluk K, Moldoveanu Z, Sanders J T, et al. Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis[J]. Kidney Int, 2011, 80(1): 79-87. doi: 10.1038/ki.2011.16 pmid: 21326171
[22]	Mir S, Yavascan O, Mutlubas F, et al. Clinical outcome in children with Henoch-Schönlein nephritis[J]. Pediatr Nephrol, 2007, 22(1): 64-70. doi: 10.1007/s00467-006-0278-0 pmid: 17024391
[23]	冯丹, 郝胜, 钮小玲, 等. 儿童紫癜性肾炎预后的相关因素分析[J]. 中华实用儿科临床杂志, 2016, (9): 679-682.
[24]	Counahan R, Winterborn MH, White RH, et al. Prognosis of Henoch-Schönlein nephritis in children[J]. Br Med J, 1977, 2(6078): 11-14.
[25]	Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Schönlein purpura[J]. Pediatr Nephrol, 2003, 18(5): 471-473. doi: 10.1007/s00467-003-1132-2 pmid: 12736812
[26]	Wakaki H, Ishikura K, Hataya H, et al. Henoch-Schönlein purpura nephritis with nephrotic state in children: predictors of poor outcomes[J]. Pediatr Nephrol, 2011, 26(6): 921-925. doi: 10.1007/s00467-011-1827-8 pmid: 21373776
[27]	刘钧菲, 王华. 过敏性紫癜患儿抗凝纤溶系统标志物的动态变化[J]. 临床儿科杂志, 2012, 30(6): 547-551.
[28]	李雪倩, 刘小荣, 姚兴凤, 等. 牛津分类与国际小儿肾脏病研究组分级在评价儿童紫癜性肾炎预后中的应用[J]. 中华肾脏病杂志, 2020, 36(1): 26-33. doi: 10.3760/cma.j.issn.1001-7097.2020.01.005
[29]	中华医学会儿科学分会肾脏学组. 紫癜性肾炎诊治循证指南(2016)[J]. 中华儿科杂志, 2017, 55 (9): 647-651.
[30]	Davin JC. Henoch-Schönlein purpura nephritis: pathophysiology, treatment, and future strategy[J]. Clin J Am Soc Nephrol, 2011, 6(3): 679-689. doi: 10.2215/CJN.06710810
[31]	Jelusic M, Sestan M, Cimaz R, et al. Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?[J]. Pediatr Rheumatol Online J, 2019, 17(1): 10. doi: 10.1186/s12969-019-0311-z pmid: 30819179
[32]	Edström Halling S, Söderberg MP, Berg UB. Predictors of outcome in Henoch-Schönlein nephritis[J]. Pediatr Nephrol, 2010, 25(6): 1101-1108. doi: 10.1007/s00467-010-1444-y pmid: 20174831
[33]	Coppo R, Andrulli S, Amore A, et al. Predictors of outcome in Henoch-Schönlein nephritis in children and adults[J]. Am J Kidney Dis, 2006, 47(6) : 993-1003. doi: 10.1053/j.ajkd.2006.02.178 pmid: 16731294
[34]	Roberts ISD, Cook HT, Troyanov S, et al. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility[J]. Kidney Int, 2009, 76(5): 546-556. doi: 10.1038/ki.2009.168 pmid: 19571790
[35]	Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group[J]. Kidney Int, 2017, 91(5): 1014-1021. doi: S0085-2538(17)30101-1 pmid: 28341274
[36]	Yun D, Kim DK, Oh KH, et al. MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schönlein purpura nephritis[J]. BMC Nephrol, 2020, 21(1): 33. doi: 10.1186/s12882-020-1691-5 pmid: 32000703
[37]	Wang M, Wang R, He X, et al. Using MEST-C scores and the international study of kidney disease in children classification to predict outcomes of Henoch-Schönlein purpura nephritis in children[J]. Front Pediatr, 2021, 9: 658845. doi: 10.3389/fped.2021.658845
[38]	Delbet JD, Geslain G, Auger M, et al. Histological prognostic factors in children with Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2020, 35(2): 313-320. doi: 10.1007/s00467-019-04363-y
[39]	Koskela M, Ylinen E, Ukonmaanaho EM, et al. The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2017, 32(7): 1201-1209. doi: 10.1007/s00467-017-3608-5 pmid: 28197887
[40]	Zhong X, Ding J. Diagnosis and treatment of IgA nephropathy and IgA vasculitis nephritis in Chinese children[J]. Pediatr Nephrol, 2023, 38(6): 1707-1715. doi: 10.1007/s00467-022-05798-6
[41]	Delbet JD, Parmentier C, Herbez Rea C, et al. Management of IgA vasculitis with nephritis[J]. Paediatr Drugs, 2021, 23(5): 425-435. doi: 10.1007/s40272-021-00464-0
[42]	Deki S, Hamada R, Mikami N, et al. Half of children with IgA vasculitis-associated nephritis with nephrotic state spontaneously recover[J]. Nephrology (Carlton), 2022, 27(8): 681-689. doi: 10.1111/nep.v27.8
[43]	Davin JC, Coppo R. Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis[J]. Pediatr Nephrol, 2013, 28(10): 1897-1903. doi: 10.1007/s00467-013-2550-4
[44]	Ozen S, Marks SD, Brogan P, et al. European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative[J]. Rheumatology (Oxford), 2019, 58(9): 1607-1616. doi: 10.1093/rheumatology/kez041 pmid: 30879080
[45]	Kawasaki Y, Suzuki J, Nozawa R, et al. Efficacy of methylprednisolone and urokinase pulse therapy for severe Henoch-Schönlein nephritis[J]. Pediatrics, 2003, 111(<W>4 Pt 1):785-789. doi: 10.1542/peds.111.4.785 pmid: 12671112
[46]	Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review[J]. Front Immunol, 2021, 12: 771619. doi: 10.3389/fimmu.2021.771619
[47]	Novak J, Rizk D, Takahashi K, et al. New insights into the pathogenesis of IgA nephropathy[J]. Kidney Dis (Basel), 2015, 1(1): 8-18.
[48]	Zhao N, Hou P, Lv J, et al. The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression[J]. Kidney Int, 2012, 82(7): 790-796. doi: 10.1038/ki.2012.197 pmid: 22673888
[49]	Heineke MH, Ballering AV, Jamin A, et al. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura)[J]. Autoimmun Rev, 2017, 16(12): 1246-1253. doi: S1568-9972(17)30259-8 pmid: 29037908
[50]	Launay P, Grossetête B, Arcos-Fajardo M, et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice[J]. J Exp Med, 2000, 191(11): 1999-2009. doi: 10.1084/jem.191.11.1999 pmid: 10839814
[51]	Vuong MT, Hahn-Zoric M, Lundberg S, et al. Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy[J]. Kidney Int, 2010, 78(12): 1281-1287. doi: 10.1038/ki.2010.314 pmid: 20811333
[52]	Davin JC, Ten Berge IJ, Weening JJ. What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?[J]. Kidney Int, 2001, 59(3): 823-834. doi: 10.1046/j.1523-1755.2001.059003823.x pmid: 11231337
[53]	Yang YH, Tsai IJ, Chang CJ, et al. The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schönlein Purpura[J]. PLoS One, 2015, 10(3): e0120411. doi: 10.1371/journal.pone.0120411
[54]	Dumont C, Mérouani A, Ducruet T, et al. Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura[J]. Pediatr Nephrol, 2020, 35(5): 843-850. doi: 10.1007/s00467-019-04445-x pmid: 31932958
[55]	Takemura T, Yoshioka K, Murakami K, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis[J]. Virchows Arch, 1994, 424(5): 459-464. pmid: 8032526
[56]	Del Vecchio GC, Penza R, Altomare M, et al. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura[J]. Immunopharmacol Immunotoxicol, 2008, 30(3): 623-629. doi: 10.1080/08923970801973646
[57]	Wu H, Wen Y, Yue C, et al. Serum TNF-α level is associated with disease severity in adult patients with immunoglobulin A vasculitis nephritis[J]. Dis Markers, 2020: 1-7.
[58]	Wang K, Sun X, Jing S, et al. Development and validation of nomogram prediction model for severe kidney disease in children with Henoch-Schönlein purpura: A prospective analysis of two independent cohorts-forecast severe kidney disease outcome in 2,480 hospitalized Henoch-Schönlein purpura children[J]. Front Immunol, 2022, 13: 999491. doi: 10.3389/fimmu.2022.999491
[59]	He M, Li C, Kang Y, et al. Clinical predictive model for the 1-year remission probability of IgA vasculitis nephritis[J]. Int Immunopharmacol, 2021, 101(Pt B): 108341.
[60]	Song Z, Nie Y, Yang L, et al. Predicting severe renal and gastrointestinal involvement in childhood immunoglobulin A vasculitis with routine laboratory parameters[J]. Dermatology, 2022, 238(4): 745-752. doi: 10.1159/000519665
[61]	Wang J, Chu H, Pan Y. Prediction of renal damage in children with IgA vasculitis based on machine learning[J]. Medicine (Baltimore), 2022, 101(42): e31135. doi: 10.1097/MD.0000000000031135

Analysis of prognostic risk factors of IgA vasculitis with nephritis in children

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 61

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LUO Mingjing, YU Jiaming, WANG Xiaodong, ZHANG Xiaoling, YU Yue, ZHANG Yu, WEN Feiqiu, LIU Sixi. Clinical analysis of invasive fungal disease secondary to allogeneic hematopoietic stem cell transplantation in 424 children with thalassemia [J]. Journal of Clinical Pediatrics, 2025, 43(1): 21-28.
[2]	LIU Dongxia, JIN Rong, LIN Rongjun. Risk factors analysis of severe refractory Mycoplasma pneumoniae pneumonia complicated with bronchitis obliterans in children [J]. Journal of Clinical Pediatrics, 2025, 43(1): 29-34.
[3]	ZHONG Jinhong, WANG Can, CHEN Fang. Progress in the research of infantile fiberoptic bronchoscopy sedation [J]. Journal of Clinical Pediatrics, 2025, 43(1): 50-55.
[4]	JIANG Weiqin, WANG Jing, CHENG Anna, CHEN Tingting, HUANG Yujuan. Predictors of recurrent febrile seizures during the same febrile illness in children with febrile seizures [J]. Journal of Clinical Pediatrics, 2025, 43(1): 8-13.
[5]	QIU Xiu, WEI Dongmei, LIN Shanshan, XIA Huimin, ZHOU Wenhao. Principles and practice of the Born in Guangzhou Cohort Study [J]. Journal of Clinical Pediatrics, 2024, 42(9): 747-752.
[6]	FAN Jianxia. The origins and development of the healthy life trajectory program: a cohort of community-family-mother-child multidimensional interventions for overweight and obesity in children [J]. Journal of Clinical Pediatrics, 2024, 42(9): 768-773.
[7]	JIANG Tao, LI Shuangjie, TANG Lian, OUYANG Wenxian. Immunobiological properties of peripheral blood MAIT cells in children with chronic hepatitis B [J]. Journal of Clinical Pediatrics, 2024, 42(9): 787-790.
[8]	ZHOU Jie, LIU Keqiang, WANG Jinling, WANG Ying. Megacystis-microcolon-intestinal hypoperistalsis syndrome caused by MYH11 elongating mutation : a case report and literatures review [J]. Journal of Clinical Pediatrics, 2024, 42(9): 798-804.
[9]	CHU Sijia, TANG Jihong. Research progress of central nervous system injury associated with pediatric acute lymphoblastic leukemia and its treatment [J]. Journal of Clinical Pediatrics, 2024, 42(9): 811-816.
[10]	DING Yaping, XIA Shanshan, ZHANG Chenmei. Interpretation of “2023 Children’s Renal Nutrition Working Group Clinical Practice Recommendations: Nutritional Management of Children with Acute Kidney Injury” [J]. Journal of Clinical Pediatrics, 2024, 42(8): 667-672.
[11]	LI Yirong, LI Huiping, GAO Jingyu, XIAO Yuhua, CHEN Xiaomin, LU Yanling, ZHAO Nana, FENG Xiaoqin. Comparison of different doses of cytarabine for induction chemotherapy in children with acute myeloid leukemia in FLAG-IDA regimen [J]. Journal of Clinical Pediatrics, 2024, 42(8): 673-677.
[12]	HUANG Bo, DONG Yanying, SONG Linlan. Clinical characteristics of 348 children with infectious mononucleosis [J]. Journal of Clinical Pediatrics, 2024, 42(8): 678-683.
[13]	WANG Dan, SHAO Jingbo, LI Hong, ZHANG Na, ZHU Jiashi, FU Pan, WANG Zhen. Clinical analysis of 38 cases of hematological malignancies complicated with tumor lysis syndrome in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 684-690.
[14]	MA Yan, WEI Xingjiao, BAI Hua, ZHANG Yan, TIAN Xinmin, Aqsa Ahmad, LIANG Lijun. Analysis of etiological composition and clinical features of stage 5 chronic kidney disease in children in a tertiary hospital in western China [J]. Journal of Clinical Pediatrics, 2024, 42(8): 697-703.
[15]	WANG Ye, ZHANG Linlin, CHI Zuofei, SUN Ruowen, JIANG Zehui, XU Gang. A case of clinical report of T-lymphoblastic lymphoma secondary to acute promyelocytic leukemia in children [J]. Journal of Clinical Pediatrics, 2024, 42(8): 722-727.